585 pregnant women were investigated with both conventional sonographic examination and color Doppler examination. The cases with intrauterine growth retardation, preeclampsia, twin pregnancies, congenital malformations and diabetes were excluded. The remaining 550 cases (between ages 16 and 40) were investigated in the first trimester and gestational ages were compatible with the last menstrual date. In order to evaluate fetal development, biparietal diameter, femur length, abdominal circumference, and estimated fetal weight were calculated by conventional ultrasonographic method. The application of Doppler ultrasound to the study of fetal umbilical arterial blood flow velocity is a relatively new technique. The failure to obtain useful Doppler signals was about 18-22% with pulse-wave Doppler system. Recently, color Doppler technology solved this problem. We used an ALOKA 680-SSD ultrasonography device and color Doppler ultrasonography technique and recorded umbilical arterial Doppler signals from every case and calculated classical Doppler indices – systolic/diastolic (S/D) ratio, pulsatility index (PI), Pourcelot index or resistive index (RI). Statistical comparisons were made by SPSS program. Correlation coefficient and R2 values between gestational age and other indices were calculated. The aforementioned values were r: -0.79; R2: 0.63, r: -0.71; R2: 0.50, r: -0.64; R2: 0.41, for S/D, PI, RI, respectively.

Keywords:
Color Doppler ultrasonography, Umbilical cord
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.